These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12176558)

  • 1. Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients.
    Pozzetto U; Citterio F; Romagnoli J; Scatà M; Nanni G; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1740-2. PubMed ID: 12176558
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
    Undre NA; Schäfer A
    Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
    [No Abstract]   [Full Text] [Related]  

  • 5. Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression.
    Khoury N; Kriaa F; Hiesse C; Von Ey F; Durbach A; Ammor M; Hafi A; Djeffal R; Boubenider S; Droupy S; Hammoudi Y; Eschwege P; Benoît G; Charpentier B
    Transplant Proc; 2000 Dec; 32(8):2763-4. PubMed ID: 11134791
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients.
    Koefoed-Nielsen PB; Jørgensen KA
    Transplant Proc; 2002 Aug; 34(5):1743-4. PubMed ID: 12176559
    [No Abstract]   [Full Text] [Related]  

  • 7. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
    Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
    Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.
    Webb NJ; Stevenson PJ; Lewis MA; Postlethwaite RJ; Bradbury MG; Undre N
    Transplant Proc; 2002 Aug; 34(5):1948-50. PubMed ID: 12176639
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia.
    Kohnle M; Lütkes P; Zimmermann U; Philipp T; Heemann U
    Transplant Proc; 1999 Nov; 31(7A):44S-45S. PubMed ID: 10576043
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up.
    Brunet M; Torregrosa JV; Oppenheimer F; Corbella J
    Transplant Proc; 1998 Dec; 30(8):4068-9. PubMed ID: 9865298
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
    Hu RH; Lee PH; Tsai MK
    Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
    Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
    Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic monitoring of lymphocyte proliferation and TGF-beta 1 expression at cyclosporine a (CyA) trough levels (C(0)) and 2 hours after intake (C(2)) of CyA in human renal allograft recipients.
    Böhler T; Budde K; Schneider M; Eliazyfer S; Dell K; Einecke G; Diekmann F; Fritsche L; Mai I; Neumayer HH; Waiser J
    Transplant Proc; 2001; 33(7-8):3148-50. PubMed ID: 11750352
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
    Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
    Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter trial of FK506 as rescue therapy for renal transplant recipients in Taiwan.
    Shu KH; Cheng CH; Wu MJ; Lian JD; Huang CC; Chu SH; Chiang YJ; Lai MK; Lee PH
    Transplant Proc; 1998 Nov; 30(7):3584-6. PubMed ID: 9838570
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High QT dispersion in tacrolimus-treated kidney transplant recipients.
    Gerhardt U; Suwelack B; Pawolka A; Hohage H
    Transplant Proc; 2001 May; 33(3):2148-50. PubMed ID: 11377482
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal time for determination of blood tacrolimus level.
    Jørgensen KA; Povlsen JV; Poulsen JH
    Transplant Proc; 2001; 33(7-8):3164-5. PubMed ID: 11750358
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.